Wang HM - Search Results

1

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.

Zhao M, Guo Z, Zou YH, Li X, Yan ZP, Chen MS, Fan WJ, Li HL, Yang JJ, Chen XM, Xu LF, Zhang YW, Zhu KS, Sun JH, Li JP, Jin Y, Yu HP, Duan F, Xiong B, Yin GW, Lin HL, Ma YL, Wang HM, Gu SZ, Si TG, Wang XD, Zhao C, Yu WC, Guo JH, Zhai J, Huang YH, Wang WY, Lin HF, Gu YK, Chen JZ, Wang JP, Zhang YM, Yi JZ, Lyu N. Zhao M, et al. Among authors: wang xd, wang wy, wang jp, wang hm. Hepatol Int. 2024 Feb;18(1):4-31. doi: 10.1007/s12072-023-10599-6. Epub 2023 Oct 21. Hepatol Int. 2024. PMID: 37864725

2

MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.

Xie H, Yu H, Tian S, Yang X, Wang X, Wang H, Guo Z. Xie H, et al. Oncotarget. 2018 Jan 11;9(20):15252-15265. doi: 10.18632/oncotarget.24165. eCollection 2018 Mar 16. Oncotarget. 2018. PMID: 29632641 Free PMC article.

3

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Qin S, Li Q, Gu S, Chen X, Lin L, Wang Z, Xu A, Chen X, Zhou C, Ren Z, Yang L, Xu L, Bai Y, Chen L, Li J, Pan H, Cao B, Fang W, Wu W, Wang G, Cheng Y, Yu Z, Zhu X, Jiang D, Lu Y, Wang H, Xu J, Bai L, Liu Y, Lin H, Wu C, Zhang Y, Yan P, Jin C, Zou J. Qin S, et al. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):559-568. doi: 10.1016/S2468-1253(21)00109-6. Epub 2021 May 8. Lancet Gastroenterol Hepatol. 2021. PMID: 33971141 Clinical Trial.

4

What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis.

Xie H, Yu H, Tian S, Yang X, Wang X, Yang Z, Wang H, Guo Z. Xie H, et al. Oncotarget. 2017 Aug 10;8(59):100508-100523. doi: 10.18632/oncotarget.20119. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245997 Free PMC article.

5

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma.

Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z. Xie H, et al. Onco Targets Ther. 2018 May 31;11:3257-3265. doi: 10.2147/OTT.S165000. eCollection 2018. Onco Targets Ther. 2018. PMID: 29910621 Free PMC article.

6

Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma.

Xie H, Xue YQ, Liu P, Zhang PJ, Tian ST, Yang Z, Guo Z, Wang HM. Xie H, et al. Among authors: wang hm. World J Gastroenterol. 2018 Jan 21;24(3):371-378. doi: 10.3748/wjg.v24.i3.371. World J Gastroenterol. 2018. PMID: 29391759 Free PMC article.

7

Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.

Xie H, Guo JH, An WM, Tian ST, Yu HP, Yang XL, Wang HM, Guo Z. Xie H, et al. Among authors: wang hm. World J Gastroenterol. 2017 Mar 28;23(12):2159-2167. doi: 10.3748/wjg.v23.i12.2159. World J Gastroenterol. 2017. PMID: 28405143 Free PMC article.

8

Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia.

Zhou L, Zhang LZ, Wang JY, Li YW, Hu HD, Peng XM, Zhao Y, Wang XM, Xie H, Liu CZ, Wang HM. Zhou L, et al. Among authors: wang jy, wang xm, wang hm. Mol Clin Oncol. 2017 Sep;7(3):435-442. doi: 10.3892/mco.2017.1345. Epub 2017 Jul 25. Mol Clin Oncol. 2017. PMID: 28811901 Free PMC article.

9

The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients.

Xie H, Wang H, An W, Ma W, Qi R, Yang B, Liu C, Gao Y, Xu B, Wang W. Xie H, et al. PLoS One. 2014 Feb 20;9(2):e89081. doi: 10.1371/journal.pone.0089081. eCollection 2014. PLoS One. 2014. PMID: 24586515 Free PMC article.

10

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.

Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, Bai W, Dong Z, Lu Y, Zeng Z, Lou M, Wang H, Gao X, Chang X, An L, Qu J, Li J, Yang Y. Wang C, et al. Hepatology. 2015 May;61(5):1579-90. doi: 10.1002/hep.27548. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25284802 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,712 results

Search Page